Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities.
Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.
Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1.
A small-molecule screen yields idiotype-specific blockers of neuromyelitis optica-immunoglobulin G binding to aquaporin-4.
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.
Callosal atrophy in multiple sclerosis is related to cognitive speed.
Brain circuitry outside the synaptic cleft.
Autophagic myelin destruction by schwann cells during wallerian degeneration and segmental demyelination.
Effectiveness of Energy-Conservation treatment in reducing fatigue in Multiple Sclerosis: a systematic review and meta-analysis.
Genotype-phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosis.
Multiple sclerosis in Pakistan: histocompatibility antigen composition and disability.
The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis.
The Puerto Rico study for the prevalence of Multiple Sclerosis.
Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis.
Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy: Observations Based on Real-World Data.
The effect of intravenous immunoglobulin on neuromyelitis optica.
Fingolimod-induced asthma deterioration in a patient with relapsing-remitting multiple sclerosis.
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Patients' experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey.
The dynamics of finger tremor in multiple sclerosis is affected by whole body position.
Balance and Gait in People with Multiple Sclerosis: A Comparison with Healthy Controls and the Immediate Change after an Intervention based on the Bobath Concept.
Multiple sclerosis and the spinal cord.
The Ex Vivo Production of IL-6 and IL-21 by CD4(+) T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients.
Pages
« first
‹ previous
…
192
193
194
195
196
197
198
199
200
…
next ›
last »